Age-Related Macular Degeneration (AMD): Types, Symptoms, and Early Action
Epidemiology
Leading cause of irreversible central vision loss in adults >50 in developed nations. Prevalence rises sharply with age.
Two Forms
| Feature | Dry (Atrophic) AMD | Wet (Neovascular) AMD |
|---|---|---|
| Prevalence | 80–90% | 10–20% |
| Pathology | Drusen, RPE atrophy, geographic atrophy | Choroidal neovascularization (CNV) → leakage, hemorrhage |
| Progression | Gradual (years) | Rapid (weeks–months) |
| Vision loss | Slow, central scotoma | Sudden, severe distortion/loss |
Symptoms
- Central blurring, metamorphopsia (straight lines wavy)
- Dark/empty central spot
- Difficulty reading, recognizing faces, low-light vision
Management
- Dry: AREDS2 supplements (vitamins C, E, lutein, zeaxanthin, zinc, copper) slow progression in intermediate/advanced unilateral. Lifestyle: smoking cessation, UV protection, cardiovascular health.
- Wet: Anti-VEGF intravitreal injections (aflibercept, ranibizumab, faricimab, brolucizumab) – mainstay; monthly or treat-and-extend. Photodynamic therapy (rare).
Urgency
New distortion or vision drop → same-week ophthalmology. Early anti-VEGF preserves vision.
Eye & Vision Disorders - Related Articles
- Sudden Eye Floaters: Causes, Risks & When to See a Doctor
- A Brief History of Contact Lenses: From Da Vinci to Modern Innovation
- Emergency Eye Care: Immediate Steps for Super Glue Exposure
- Understanding and Reducing Eyeglass Glare: Causes, Risks, and Solutions
- Living Well with Low Vision: A Comprehensive Adaptation Guide
- Synoptic Phototherapy: Restoring Vision with Light Therapy
- Reduce Eye Strain & Improve Vision with Simple Exercises
